Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
The development of an industrial process should begin right at the start – the preclinical stage.
A new center for electron bio-imaging was officially opened by one of the three Nobel Prize winners.
Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.
Where would drug development be without liquid chromatography-mass spectrometry – the hyphenated technique more commonly known as LC-MS?
A robotic arm takes mass spec analysis of 3D objects to the next level.
Making cancer drugs cheaper and more effective – with a paper “coffee” filter.
mAbs are an important growth area for the biopharma industry – so we need more effective purification technologies.
Streamlined workflows help scientists plot a course for painless peptide mapping
The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.
Why does the full potential of biosimilars remain untapped? Four experts weigh in.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.